These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8005243)
1. Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up. Agustí C; Xaubet A; Agustí AG; Roca J; Ramirez J; Rodriguez-Roisin R Eur Respir J; 1994 Apr; 7(4):643-50. PubMed ID: 8005243 [TBL] [Abstract][Full Text] [Related]
2. Determinants of progression in idiopathic pulmonary fibrosis. Schwartz DA; Van Fossen DS; Davis CS; Helmers RA; Dayton CS; Burmeister LF; Hunninghake GW Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 1):444-9. PubMed ID: 8306043 [TBL] [Abstract][Full Text] [Related]
3. Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis. van Oortegem K; Wallaert B; Marquette CH; Ramon P; Perez T; Lafitte JJ; Tonnel AB Eur Respir J; 1994 Nov; 7(11):1950-7. PubMed ID: 7875264 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis. Behr J; Adelmann-Grill BC; Krombach F; Beinert T; Schwaiblmair M; Fruhmann G Thorax; 1993 Jul; 48(7):736-42. PubMed ID: 8153923 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Nathan SD; Shlobin OA; Ahmad S; Urbanek S; Barnett SD Chest; 2007 Mar; 131(3):657-663. PubMed ID: 17356077 [TBL] [Abstract][Full Text] [Related]
6. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume. Johnson DC Respir Med; 2000 Jan; 94(1):28-37. PubMed ID: 10714476 [TBL] [Abstract][Full Text] [Related]
7. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Hamada K; Nagai S; Tanaka S; Handa T; Shigematsu M; Nagao T; Mishima M; Kitaichi M; Izumi T Chest; 2007 Mar; 131(3):650-656. PubMed ID: 17317730 [TBL] [Abstract][Full Text] [Related]
8. DLCO/Q and diffusion limitation at rest and on exercise in patients with interstitial fibrosis. Hughes JM; Lockwood DN; Jones HA; Clark RJ Respir Physiol; 1991 Feb; 83(2):155-66. PubMed ID: 2068413 [TBL] [Abstract][Full Text] [Related]
9. Determinants of survival in idiopathic pulmonary fibrosis. Schwartz DA; Helmers RA; Galvin JR; Van Fossen DS; Frees KL; Dayton CS; Burmeister LF; Hunninghake GW Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 1):450-4. PubMed ID: 8306044 [TBL] [Abstract][Full Text] [Related]
10. Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease. Someya F; Mugii N; Hasegawa M; Yahata T; Nakagawa T Respir Care; 2014 Jan; 59(1):75-80. PubMed ID: 23764864 [TBL] [Abstract][Full Text] [Related]
12. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis. Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509 [TBL] [Abstract][Full Text] [Related]
13. Lung function in children and adolescents with idiopathic interstitial pulmonary fibrosis. Zapletal A; Houstĕk J; Samánek M; Copová M; Paul T Pediatr Pulmonol; 1985; 1(3):154-66. PubMed ID: 3877269 [TBL] [Abstract][Full Text] [Related]
14. Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Implications for further studies. Dayton CS; Schwartz DA; Helmers RA; Pueringer RJ; Gilbert SR; Merchant RK; Hunninghake GW Chest; 1993 Jan; 103(1):69-73. PubMed ID: 8417939 [TBL] [Abstract][Full Text] [Related]
15. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Ziegenhagen MW; Zabel P; Zissel G; Schlaak M; Müller-Quernheim J Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):762-8. PubMed ID: 9517588 [TBL] [Abstract][Full Text] [Related]
16. Impaired Carbon Monoxide Diffusing Capacity is the strongest lung function predictor of decline in 12 minute-walking distance in COPD; a 5-year follow-up study. Farkhooy A; Janson C; Arnardóttir RH; Emtner M; Hedenström H; Malinovschi A COPD; 2015 Jun; 12(3):240-8. PubMed ID: 25208266 [TBL] [Abstract][Full Text] [Related]
17. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Silver RM; Miller KS; Kinsella MB; Smith EA; Schabel SI Am J Med; 1990 May; 88(5):470-6. PubMed ID: 2337105 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Qiu M; Chen Y; Ye Q Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Agustí AG; Roca J; Gea J; Wagner PD; Xaubet A; Rodriguez-Roisin R Am Rev Respir Dis; 1991 Feb; 143(2):219-25. PubMed ID: 1990931 [TBL] [Abstract][Full Text] [Related]
20. Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial. Raghu G; van den Blink B; Hamblin MJ; Brown AW; Golden JA; Ho LA; Wijsenbeek MS; Vasakova M; Pesci A; Antin-Ozerkis DE; Meyer KC; Kreuter M; Santin-Janin H; Mulder GJ; Bartholmai B; Gupta R; Richeldi L JAMA; 2018 Jun; 319(22):2299-2307. PubMed ID: 29800034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]